These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 25909886)
1. Tissue-specific targeting of cell fate regulatory genes by E2f factors. Julian LM; Liu Y; Pakenham CA; Dugal-Tessier D; Ruzhynsky V; Bae S; Tsai SY; Leone G; Slack RS; Blais A Cell Death Differ; 2016 Apr; 23(4):565-75. PubMed ID: 25909886 [TBL] [Abstract][Full Text] [Related]
2. Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors. Kel AE; Kel-Margoulis OV; Farnham PJ; Bartley SM; Wingender E; Zhang MQ J Mol Biol; 2001 May; 309(1):99-120. PubMed ID: 11491305 [TBL] [Abstract][Full Text] [Related]
3. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Araki K; Nakajima Y; Eto K; Ikeda MA Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826 [TBL] [Abstract][Full Text] [Related]
4. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide identification of potential plant E2F target genes. Vandepoele K; Vlieghe K; Florquin K; Hennig L; Beemster GT; Gruissem W; Van de Peer Y; Inzé D; De Veylder L Plant Physiol; 2005 Sep; 139(1):316-28. PubMed ID: 16126853 [TBL] [Abstract][Full Text] [Related]
6. E2F Transcription Factors Control the Roller Coaster Ride of Cell Cycle Gene Expression. Thurlings I; de Bruin A Methods Mol Biol; 2016; 1342():71-88. PubMed ID: 26254918 [TBL] [Abstract][Full Text] [Related]
7. Combinatorial gene control involving E2F and E Box family members. Giangrande PH; Zhu W; Rempel RE; Laakso N; Nevins JR EMBO J; 2004 Mar; 23(6):1336-47. PubMed ID: 15014447 [TBL] [Abstract][Full Text] [Related]
9. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Aslanian A; Iaquinta PJ; Verona R; Lees JA Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242 [TBL] [Abstract][Full Text] [Related]
10. The identification of E2F1-specific target genes. Wells J; Graveel CR; Bartley SM; Madore SJ; Farnham PJ Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3890-5. PubMed ID: 11904439 [TBL] [Abstract][Full Text] [Related]
11. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity. Callaghan DA; Dong L; Callaghan SM; Hou YX; Dagnino L; Slack RS Dev Biol; 1999 Mar; 207(2):257-70. PubMed ID: 10068462 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. de Bruin A; Maiti B; Jakoi L; Timmers C; Buerki R; Leone G J Biol Chem; 2003 Oct; 278(43):42041-9. PubMed ID: 12893818 [TBL] [Abstract][Full Text] [Related]
13. E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation. Asp P; Acosta-Alvear D; Tsikitis M; van Oevelen C; Dynlacht BD Genes Dev; 2009 Jan; 23(1):37-53. PubMed ID: 19136625 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the Arf/p53 tumor surveillance network by E2F. Iaquinta PJ; Aslanian A; Lees JA Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts. Kim TA; Ravitz MJ; Wenner CE J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288 [TBL] [Abstract][Full Text] [Related]
17. RBL2-E2F-GCN5 guide cell fate decisions during tissue specification by regulating cell-cycle-dependent fluctuations of non-cell-autonomous signaling. Militi S; Nibhani R; Jalali M; Pauklin S Cell Rep; 2023 Sep; 42(9):113146. PubMed ID: 37725511 [TBL] [Abstract][Full Text] [Related]
18. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors. Itoh A; Levinson SF; Morita T; Kourembanas S; Brody JS; Mitsialis SA Cell Mol Biol Res; 1995; 41(3):147-54. PubMed ID: 8589754 [TBL] [Abstract][Full Text] [Related]
19. Activation and repression of p21(WAF1/CIP1) transcription by RB binding proteins. Gartel AL; Goufman E; Tevosian SG; Shih H; Yee AS; Tyner AL Oncogene; 1998 Dec; 17(26):3463-9. PubMed ID: 10030670 [TBL] [Abstract][Full Text] [Related]
20. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence. Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]